Part 2/7:
Despite the impressive bid, Monsanto has rejected Bayer's initial offer while leaving the door slightly ajar for further negotiations. Market reactions reflect skepticism, as the share price remains considerably below the offered price. Current evaluations place Monsanto's market value at around $50 billion, making Bayer's offer not particularly enticing at this point. This hesitance is echoed by financial analysts and market observers who are questioning the feasibility of such a monumental merger.